| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $21.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.25 | $64,372.71 | -0.1% | -6.1% | +49.4% | |
| Dec 13, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.96 | $79,598.05 | -0.1% | -13.3% | -5.9% | |
| Nov 29, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.75 | $77,785.51 | -0.1% | -12.8% | -20.3% | |
| Nov 16, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 17,770 | $11.12 | $197,609.51 | -0.2% | -26.0% | -40.7% | |
| Jan 4, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 9,625 | $18.03 | $173,528.16 | -0.1% | -56.7% | -56.6% | |
| Dec 21, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 9,625 | $18.75 | $180,478.38 | -0.1% | -65.0% | -59.1% | |
| Dec 7, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 9,625 | $20.32 | $195,533.45 | - | -65.8% | -55.0% | |
| Nov 18, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 9,625 | $18.91 | $182,005.12 | - | -39.6% | -48.9% |